Plain-English translation of NCT07232537 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is watching how finerenone—a medication that protects the kidneys—is used in real-world medical practice in South Korea. Researchers will collect information from about 500 people with chronic kidney disease and type 2 diabetes who are prescribed this medication by their doctors. The goal is to understand how well the medication works and how safe it is when used in everyday clinical care, rather than in a controlled research setting.
Chronic kidney disease caused by type 2 diabetes is a serious problem that damages the kidneys over time. While this medication has been approved to help protect kidneys, researchers want to gather more information about how it's actually used and how it performs in Korean patients to make sure it's as safe and effective as possible.
You likely qualify if…
You likely don't qualify if…
You will continue receiving the medication from your regular doctor as prescribed—the study doesn't change your treatment. Researchers will collect information from your medical records about your kidney and heart health, your blood pressure, what dose you're taking, any other medications you use, and how long you stay on the treatment. The study simply observes and documents your care over time rather than asking you to do anything different.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
South Korea